# DESCRIPTION

## FIELD OF THE INVENTION

- introduce molecular pathway regulation

## BACKGROUND

- describe mitochondrial function
- explain response to low oxygen levels
- introduce HIF-1α protein
- describe HIF-1α-dependent reprogramming
- discuss Warburg effect
- explain role of aerobic glycolysis
- describe regulation of cellular metabolism
- introduce MUL1 E3 ubiquitin ligase
- describe MUL1's role in various biological pathways

## SUMMARY OF THE INVENTION

- introduce MUL1's role in regulating mitochondrial metabolism
- describe metabolic phenotype of MUL1(−/−) cells
- investigate mechanism of MUL1 regulation
- identify HIF-1α and Akt2 as mediators of MUL1 function
- describe MUL1 ligase regulation of HIF-1α and Akt2
- use chemical inhibitors and activators to investigate HIF-1α and Akt2
- describe significance of MUL1 pathway in animals
- provide new paradigm for treatment of obesity
- reveal new function of MUL1 in regulating mitochondrial metabolism
- reveal new function of MUL1 in regulating lipogenesis and adiposity
- provide new MUL1 molecular pathway for targeting in drug development
- provide inactivators of MUL1
- provide downregulators of MUL1 expression
- provide pharmacological modulators of MUL1
- provide pharmacological regulators of MUL1
- provide modulator of mitochondrial MUL1 E3 ubiquitin ligase
- provide regulator of mitochondrial MUL1 E3 ubiquitin ligase
- provide pharmaceutical composition including modulator or regulator
- provide method for inhibiting MUL1 in a cell
- provide method for inhibiting MUL1 in a subject
- provide method for treating condition responsive to MUL1 regulation
- provide method for preventing and/or reversing weight gain and/or obesity

## DETAILED DESCRIPTION OF THE INVENTION

- introduce MUL1-mediated K48-polyubiquitination regulation of metabolism

### Introduction to Experimentation—Study One—In Vitro Aspects

- describe mitochondrial function and regulation
- introduce MUL1 as a mitochondrial E3 ubiquitin ligase
- describe MUL1-mediated K48-polyubiquitination and its effects
- introduce Akt2 and HIF-1α as substrates of MUL1
- describe the new function of MUL1 in regulating metabolism

### Materials and Methods—Experiments Using Cells

- describe cell culture and chemicals used
- describe SDS-PAGE and Western blot analysis
- describe generation of HEK293 Akt2(−/−) and HeLa Mul1(−/−) using CRISPR/Cas9
- describe glycolytic stress assay
- describe mitochondrial stress assay
- describe stable isotope tracer experiment for NMR spectroscopy
- describe extraction of metabolites and NMR analysis
- describe 13C-NMR analysis of glutamate isotopomers
- describe fluxomic analysis using 13C-isotopomer data
- describe LC-MS analysis for metabolomics and lipidomics
- describe metabolomics data analysis
- describe lipidomic data analysis
- describe RNA sequencing analysis
- describe statistical analysis
- describe cell culture conditions
- describe chemical treatments
- describe Western blot antibodies used
- describe CRISPR/Cas9 gene editing
- describe glycolytic stress test protocol
- describe mitochondrial stress test protocol
- describe NMR spectroscopy protocol
- describe 13C-NMR data processing
- describe fluxomic analysis software
- describe LC-MS metabolomics protocol
- describe LC-MS lipidomics protocol
- describe metabolomics data processing
- describe lipidomics data processing
- describe RNA sequencing protocol
- describe statistical analysis software
- describe data normalization
- describe data transformation
- describe pathway analysis
- describe data visualization

### Results-Study One

- introduce MUL1 E3 ubiquitin ligase
- describe MUL1-mediated K48-polyubiquitination
- list MUL1 substrates
- show protein level of UBXN7, HIF-1α, AKT, ULK1, and MFN2 in HEK293
- describe absence of MUL1 ligase
- show accumulation of substrate proteins
- define AKT family
- determine which AKT is regulated by MUL1
- show protein level of Akt1, Akt2, and Akt3
- describe activation of Akt2
- verify results in HeLa MUL1(−/−) cells
- identify new substrate of MUL1
- describe regulation of HIF-1α by UBXN7
- describe regulation of NRF2 by UBXN7
- describe coactivation of Akt2 and HIF-1α
- investigate glycolytic function
- use specific inhibitors
- show glycolytic function in HEK293 WT and MUL1(−/−) cells
- describe mitochondrial respiration assay
- show OCR of HEK293 WT and MUL1(−/−) cells
- quantify data
- describe inhibitors of mitochondrial respiration
- investigate metabolic flux
- use NMR-based 13C-isotopomer analysis
- show glutamate 13C-isotopomer distribution
- estimate metabolic flux rates
- compare metabolic models
- investigate effect of MUL1 knock-out on energy metabolism
- investigate role of HIF-1α in glycolysis
- activate HIF-1α in HEK293 Akt2(−/−) cells
- investigate effect of HIF-1α on metabolism
- describe metabolic flux analysis results

### Discussion of Experimentation—Study One

- introduce metabolic reprogramming
- describe mitochondrial function
- motivate MUL1 E3 ubiquitin ligase
- summarize MUL1's functions
- describe MUL1's ubiquitination types
- introduce Akt2 and HIF-1α coregulation
- describe metabolic changes in MUL1(−/−) cells
- present metabolomics and genomic analyses
- identify perturbed metabolic pathways
- describe lipidomic analysis results
- summarize MUL1's function in metabolism regulation

### Introduction to Experimentation—Study Two—In Vivo Aspects

- summarize MUL1's new function in metabolism regulation

### Experimentation Using MUL1 (−/−) Knockout (KO) Mice

- introduce MUL1 knockout mice
- describe metabolic phenotype
- analyze energy metabolism
- describe high fat diet (HFD) experiment
- analyze water, food consumption, and activity
- analyze oxygen consumption and CO2 release
- analyze respiratory exchange ratio
- show representative data
- compare VO2 and VCO2 between Mul1(−/−) and WT mice
- compare activity between Mul1(−/−) and WT mice
- compare food intake between Mul1(−/−) and WT mice
- describe metabolic phenotype of Mul1(−/−) mice
- analyze body weight
- analyze insulin and glucose tolerance
- analyze subcutaneous, epididymal, and mesenteric adipose tissue mass
- analyze liver histology
- analyze lipid deposition in liver
- analyze protein expression in liver
- introduce mitochondrial metabolism
- describe regulation of mitochondrial metabolism
- introduce MUL1 function
- describe MUL1 regulation of mitochondrial metabolic homeostasis
- describe phenotype of Mul1(−/−) mice
- analyze energy expenditure and metabolism
- analyze metabolomic and lipidomic profiles
- analyze genome-wide mRNA sequencing
- describe regulation of SCD1 by MUL1
- describe regulation of lipogenesis and β-oxidation by MUL1
- propose MUL1 as a therapeutic target
- introduce material and methods
- describe experimental animals
- describe glucose and insulin tolerance tests
- describe liver histology
- describe indirect calorimetry
- describe thermoregulation

### Results—Study Two

- introduce Mul1(−/−) mice
- describe metabolic phenotype of Mul1(−/−) mice
- summarize body weight and glucose tolerance of Mul1(−/−) mice
- describe insulin sensitivity of Mul1(−/−) mice
- show adiposity of Mul1(−/−) mice
- describe liver steatosis of Mul1(−/−) mice
- introduce oxygen consumption and energy expenditure of Mul1(−/−) mice
- describe food consumption and locomotion of Mul1(−/−) mice
- show thermoregulation of Mul1(−/−) mice
- introduce global metabolomic analysis of Mul1(+/+) and Mul1(−/−) mouse liver
- describe PCA and PLS-DA models
- identify differentially regulated metabolites
- describe liver lipidomic profiles of Mul1(+/+) and Mul1(−/−) mice
- show total lipid content and triglycerides
- describe diacylglycerol and phosphatidylcholines
- show ceramides and other lipid classes
- introduce differential gene expression in the liver of Mul1(−/−) mice
- describe mRNA sequencing results
- show heatmap of differentially regulated genes
- describe top ranked differentially regulated genes
- introduce joint metabolic pathway analysis
- describe glycerolipids and glycerophospholipid metabolism
- show fatty acid metabolism and alanine-aspartate-glutamate metabolism
- describe regulation of SCD1 pathway in lipogenesis
- show protein expression levels of SCD1 and other enzymes
- describe pattern of expression of proteins during ND or HFD

### Discussion of Experimentation—Study Two

- introduce MUL1 as a unique E3 ubiquitin ligase
- describe function of MUL1 in lipogenesis and metabolism
- summarize results of metabolomic and lipidomic studies
- describe SCD1 as a key regulator in lipid metabolism
- show correlation between SCD1 expression and obesity
- describe regulation of SCD1 expression in Mul1(−/−) mice
- introduce AMPK and its role in energy homeostasis
- describe regulation of ACC1 and FASN in Mul1(−/−) mice
- show proposed MUL1-regulated pathway in lipogenesis and b-oxidation
- describe potential supporting role of other proteins
- introduce SREBP1 and RXR transcriptional activators
- describe potential tissue-specific functions of MUL1
- summarize study and potential therapeutic applications

## Summary of Experimental Findings: The Role of Mitochondrial MUL1 E3 Ligase in the Regulation of Metabolism and Obesity

- introduce MUL1 E3 ligase
- describe MUL1's role in mitochondrial metabolism
- summarize Warburg effect
- motivate MUL1's role in fat oxidation and obesity
- describe experimental methods
- summarize results of Mul1(-/-) mice studies
- discuss therapeutic potential of MUL1 inactivation
- incorporate prior art by reference
- disclaim limitations of invention
- emphasize scope of invention

